Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages
Authors
Keywords
-
Journal
Cancer Medicine
Volume 3, Issue 2, Pages 201-214
Publisher
Wiley
Online
2014-01-13
DOI
10.1002/cam4.173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- Evidence of Heavy Methylation in the Galectin 3 Promoter in Early Stages of Prostate Adenocarcinoma: Development and Validation of a Methylated Marker for Early Diagnosis of Prostate Cancer
- (2014) Hafiz Ahmed et al. Translational Oncology
- Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors
- (2013) Weizhen Jia et al. AMERICAN JOURNAL OF PATHOLOGY
- Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
- (2013) Shun-Pei Hung et al. CELL TRANSPLANTATION
- VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
- (2013) Nicky D'Haene et al. PLoS One
- The Role of the Tumor Microenvironment in Regulating Angiogenesis
- (2013) R. S. Watnick Cold Spring Harbor Perspectives in Medicine
- TGFβ signaling plays a critical role in promoting alternative macrophage activation
- (2012) Dapeng Gong et al. BMC IMMUNOLOGY
- Role of Galectin-3 in Classical and Alternative Macrophage Activation in the Liver following Acetaminophen Intoxication
- (2012) A.-C. D. Dragomir et al. JOURNAL OF IMMUNOLOGY
- Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma
- (2012) Ana Claudia Onuchic et al. MEDIATORS OF INFLAMMATION
- Macrophages and Tissue Injury: Agents of Defense or Destruction?
- (2011) Debra L. Laskin et al. Annual Review of Pharmacology and Toxicology
- Epigenetic reprogramming as a key contributor to melanocyte malignant transformation
- (2011) Fernanda Molognoni et al. Epigenetics
- Association of galectin-3 expression with melanoma progression and prognosis
- (2011) Ewan R. Brown et al. EUROPEAN JOURNAL OF CANCER
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
- (2011) Anna I. Markowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lack of Galectin-3 Disturbs Mesenteric Lymph Node Homeostasis and B Cell Niches in the Course of Schistosoma mansoni Infection
- (2011) Felipe L. Oliveira et al. PLoS One
- Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells
- (2010) Arun Satelli et al. CANCER LETTERS
- Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
- (2010) P. Kamper et al. HAEMATOLOGICA
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-3 contributes to neonatal hypoxic–ischemic brain injury
- (2010) Christina Doverhag et al. NEUROBIOLOGY OF DISEASE
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF- 1
- (2008) C. Happel et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Transforming growth factor-β in cutaneous melanoma
- (2008) Delphine Javelaud et al. Pigment Cell & Melanoma Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started